|
Psoriasis
|
|
| |
|
| Medical Condition: |
Psoriasis |
| Facility / Clinic: |
Richmond, VA (not available in Norfolk, VA) |
| Age: |
18 - 64 |
| Gender: |
Male/Female |
| Brief Summary: |
NCR- Richmond is studying an investigational medication for Psoriasis. The investigational medication is an antibody (a kind of protein) that blocks the action of another protein in the body that is thought to be part of the cause of psoriasis. |
| Key Inclusion / Exclusion Criteria: |
- Diagnosis of chronic psoriasis vulgaris for at least 6 months
- Plaque psoriasis involving at least 15% body surface area
|
| Enrollment: |
Open |
| Patient Commitment Duration: |
26 weeks |
| Patient Compensation: |
You may be reimbursed up to $1508 for your participation. |
| Number of Visits in Study: |
12
|
|